1. Home
  2. AVDL vs MQY Comparison

AVDL vs MQY Comparison

Compare AVDL & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • MQY
  • Stock Information
  • Founded
  • AVDL 2015
  • MQY 1994
  • Country
  • AVDL Ireland
  • MQY United States
  • Employees
  • AVDL N/A
  • MQY N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • MQY Investment Bankers/Brokers/Service
  • Sector
  • AVDL Health Care
  • MQY Finance
  • Exchange
  • AVDL Nasdaq
  • MQY Nasdaq
  • Market Cap
  • AVDL 784.6M
  • MQY 784.4M
  • IPO Year
  • AVDL 1996
  • MQY N/A
  • Fundamental
  • Price
  • AVDL $9.46
  • MQY $11.29
  • Analyst Decision
  • AVDL Strong Buy
  • MQY
  • Analyst Count
  • AVDL 7
  • MQY 0
  • Target Price
  • AVDL $18.86
  • MQY N/A
  • AVG Volume (30 Days)
  • AVDL 1.2M
  • MQY 184.8K
  • Earning Date
  • AVDL 05-07-2025
  • MQY 01-01-0001
  • Dividend Yield
  • AVDL N/A
  • MQY 4.73%
  • EPS Growth
  • AVDL N/A
  • MQY N/A
  • EPS
  • AVDL N/A
  • MQY N/A
  • Revenue
  • AVDL $194,450,000.00
  • MQY N/A
  • Revenue This Year
  • AVDL $50.53
  • MQY N/A
  • Revenue Next Year
  • AVDL $32.33
  • MQY N/A
  • P/E Ratio
  • AVDL N/A
  • MQY N/A
  • Revenue Growth
  • AVDL 252.64
  • MQY N/A
  • 52 Week Low
  • AVDL $6.38
  • MQY $9.82
  • 52 Week High
  • AVDL $17.85
  • MQY $12.52
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 65.93
  • MQY 53.65
  • Support Level
  • AVDL $8.55
  • MQY $10.95
  • Resistance Level
  • AVDL $9.98
  • MQY $11.34
  • Average True Range (ATR)
  • AVDL 0.50
  • MQY 0.12
  • MACD
  • AVDL 0.11
  • MQY 0.06
  • Stochastic Oscillator
  • AVDL 77.73
  • MQY 89.05

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About MQY Blackrock MuniYield Quality Fund Inc.

Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.

Share on Social Networks: